Association analyses identify multiple new lung cancer susceptibility loci and their interactions with smoking in the Chinese population

Nature Genetics

Volumn 44, Issue 8, 2012, Pages 895-898

  Dong, Jing ^a   Hu, Zhibin ^a   Wu, Chen ^b   Guo, Huan ^c   Zhou, Baosen ^d   Lv, Jiachun ^e   Lu, Daru ^f   Chen, Kexin ^g   Shi, Yongyong ^h   Chu, Minjie ^a   Wang, Cheng ^a   Zhang, Ruyang ^a   Dai, Juncheng ^a   Jiang, Yue ^a   Cao, Songyu ^a   Qin, Zhenzhen ^a   Yu, Dianke ^b   Ma, Hongxia ^a   Jin, Guangfu ^a   Gong, Jianhang ^a   Sun, Chongqi ^a   Zhao, Xueying ^f   Yin, Zhihua ^d   Yang, Lei ^e   Li, Zhiqiang ^h   Deng, Qifei ^c   Wang, Jiucun ^f   Wu, Wei ^d   Zheng, Hong ^g   Zhou, Guoquan ^h   Chen, Hongyan ^f   Guan, Peng ^d   Peng, Zhihang ^a   Chen, Yijiang ⁱ   Shu, Yongqian ⁱ   Xu, Lin ^j   Liu, Xiangyang ^k   Liu, Li ^l   Xu, Pin ^m   Han, Baohui ^h   Bai, Chunxue ^f   Zhao, Yuxia ^d   Zhang, Haibo ⁿ   Yan, Ying ⁿ   Amos, Christopher I ^o   Chen, Feng ^a   Tan, Wen ^b   Jin, Li ^f   Wu, Tangchun ^c   Lin, Dongxin ^b   Shen, Hongbing ^a   more..

^a NANJING MEDICAL UNIVERSITY   (China)

^b PEKING UNION MEDICAL COLLEGE   (China)

^c HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^d CHINA MEDICAL UNIVERSITY   (China)

^e GUANGZHOU MEDICAL UNIVERSITY   (China)

^f FUDAN UNIVERSITY   (China)

^g TIANJIN MEDICAL UNIVERSITY   (China)

^h SHANGHAI JIAO TONG UNIVERSITY   (China)

ⁱ THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^j JIANGSU CANCER HOSPITAL   (China)

^k CANCER HOSPITAL   (China)

^l HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^m WUHAN IRON AND STEEL GROUP CORPORATION   (China)

ⁿ Shenyang Northern Hospital   (China)

^o UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450; CYTOCHROME P450 24A1; INTERLEUKIN 3; TRANSCRIPTION FACTOR GATA 3; UNCLASSIFIED DRUG;

ARTICLE; CANCER GENETICS; CHINESE; CHROMOSOME 10P; CHROMOSOME 20Q; CHROMOSOME 5Q; CIGARETTE SMOKING; GENE INTERACTION; GENE LOCUS; GENE REPLICATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; LUNG CANCER; PRIORITY JOURNAL; SAMPLE SIZE; SINGLE NUCLEOTIDE POLYMORPHISM; VALIDATION STUDY;

ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHINA; GATA3 TRANSCRIPTION FACTOR; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; LUNG NEOPLASMS; MUSCLE PROTEINS; NERVE TISSUE PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN PHOSPHATASE 2; SMOKING; STEROID HYDROXYLASES;

EID: 84864411351     PISSN: 10614036     EISSN: 15461718     Source Type: Journal    
DOI: 10.1038/ng.2351     Document Type: Article

References (45)

1. Hu, Z. et al. A genome-wide association study identifies two new lung cancer susceptibility loci at 13q12.12 and 22q12.2 in Han Chinese. Nat. Genet. 43, 792-796 (2011).
2. McKay, J.D. et al. Lung cancer susceptibility locus at 5p15.33. Nat. Genet. 40, 1404-1406 (2008).
3. Wang, Y. et al. Common 5p15.33 and 6p21.33 variants influence lung cancer risk. Nat. Genet. 40, 1407-1409 (2008).
4. Hung, R.J. et al. A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25. Nature 452, 633-637 (2008).
5. Miki, D. et al. Variation in tp63 is associated with lung adenocarcinoma susceptibility in japanese and korean populations. Nat. Genet. 42, 893-896 (2010).
6. Amos, C.I. et al. Genome-wide association scan of tag snps identifies a susceptibility locus for lung cancer at 15q25.1. Nat. Genet. 40, 616-622 (2008).
7. Li, Y. et al. Genetic variants and risk of lung cancer in never smokers: a genome-wide association study. Lancet Oncol. 11, 321-330 (2010).
8. Ahn, M.J. et al. The 18p11.22 locus is associated with never smoker non-small cell lung cancer susceptibility in Korean populations. Hum. Genet. 131, 365-372 (2012).
9. Yoon, K.A. et al. A genome-wide association study reveals susceptibility variants for non-small cell lung cancer in the Korean population. Hum. Mol. Genet. 19, 4948-4954 (2010).
10. Thorgeirsson, T.E. et al. A variant associated with nicotine dependence, lung cancer and peripheral arterial disease. Nature 452, 638-642 (2008).
11. Zeller, T. et al. Genetics and beyond-the transcriptome of human monocytes and disease susceptibility. PLoS ONE 5, e10693 (2010).
12. Maurice, D., Hooper, J., Lang, G. & Weston, K. c-Myb regulates lineage choice in developing thymocytes via its target gene Gata3. EMBO J. 26, 3629-3640 (2007).
13. Enciso-Mora, V. et al. A genome-wide association study of Hodgkin's lymphoma identifies new susceptibility loci at 2p16.1 (REL), 8q24.21 and 10p14 (GATA3). Nat. Genet. 42, 1126-1130 (2010).
14. Yang, Y. et al. The Notch ligand Jagged2 promotes lung adenocarcinoma metastasis through a miR-200-dependent pathway in mice. J. Clin. Invest. 121, 1373-1385 (2011).
15. Tkocz, D. et al. BRCA1 and GATA3 corepress FOXC1 to inhibit the pathogenesis of basal-like breast cancers. Oncogene published online, doi:10.1038/onc.2011.531 (28 November 2011).
16. Asselin-Labat, M.L. et al. Gata-3 negatively regulates the tumor-initiating capacity of mammary luminal progenitor cells and targets the putative tumor suppressor caspase-14. Mol. Cell. Biol. 31, 4609-4622 (2011).
17. Edelman, A.M., Blumenthal, D.K. & Krebs, E.G. Protein serine/threonine kinases. Annu. Rev. Biochem. 56, 567-613 (1987).
18. Tan, J. et al. B55β-associated PP2A complex controls PDK1-directed myc signaling and modulates rapamycin sensitivity in colorectal cancer. Cancer Cell 18, 459-471 (2010).
19. Okita, K. et al. A set of genes associated with the interferon-γ response of lung cancer patients undergoing α-galactosylceramide-pulsed dendritic cell therapy. Cancer Sci. 101, 2333-2340 (2010).
20. Hsiung, C.A. et al. The 5p15.33 locus is associated with risk of lung adenocarcinoma in never-smoking females in Asia. PLoS Genet. 6, e1001051 (2010).
21. Peehl, D.M. et al. Antiproliferative effects of 1,25-dihydroxyvitamin D3 on primary cultures of human prostatic cells. Cancer Res. 54, 805-810 (1994).
22. Kim, B. et al. Clinical validity of the lung cancer biomarkers identified by bioinformatics analysis of public expression data. Cancer Res. 67, 7431-7438 (2007).
23. Anderson, M.G., Nakane, M., Ruan, X., Kroeger, P.E. & Wu-Wong, J.R. Expression of VDR and CYP24A1 mRNA in human tumors. Cancer Chemother. Pharmacol. 57, 234-240 (2006).
24. Chen, G. et al. CYP24A1 is an independent prognostic marker of survival in patients with lung adenocarcinoma. Clin. Cancer Res. 17, 817-826 (2011).
25. Matsunawa, M. et al. The aryl hydrocarbon receptor activator benzoapyrene enhances vitamin D3 catabolism in macrophages. Toxicol. Sci. 109, 50-58 (2009).
26. Yamamura, M., Modlin, R.L., Ohmen, J.D. & Moy, R.L. Local expression of antiinflammatory cytokines in cancer. J. Clin. Invest. 91, 1005-1010 (1993).
27. Huang, M. et al. Human non-small cell lung cancer cells express a type 2 cytokine pattern. Cancer Res. 55, 3847-3853 (1995).
28. Sorrentino, R. et al. Plasmacytoid dendritic cells prevent cigarette smoke and Chlamydophila pneumoniae-induced Th2 inflammatory responses. Am. J. Respir. Cell Mol. Biol. 43, 422-431 (2010).
29. Vassallo, R., Tamada, K., Lau, J.S., Kroening, P.R. & Chen, L. Cigarette smoke extract suppresses human dendritic cell function leading to preferential induction of Th-2 priming. J. Immunol. 175, 2684-2691 (2005).
30. Teodoro, J.G., Parker, A.E., Zhu, X. & Green, M.R. p53-mediated inhibition of angiogenesis through up-regulation of a collagen prolyl hydroxylase. Science 313, 968-971 (2006).
31. Dougan, M. et al. A dual role for the immune response in a mouse model of inflammation-associated lung cancer. J. Clin. Invest. 121, 2436-2446 (2011).
32. Moffatt, M.F. et al. A large-scale, consortium-based genomewide association study of asthma. N. Engl. J. Med. 363, 1211-1221 (2010).
33. Wen, G., Ringseis, R. & Eder, K. Mouse OCTN2 is directly regulated by peroxisome proliferator-activated receptor α (PPARα) via a PPRE located in the first intron. Biochem. Pharmacol. 79, 768-776 (2010).
34. Li, M.Y. et al. Roles of peroxisome proliferator-activated receptor-α and-γ in the development of non-small cell lung cancer. Am. J. Respir. Cell Mol. Biol. 43, 674-683 (2010).
35. Chen, J. et al. ACSL6 is associated with the number of cigarettes smoked and its expression is altered by chronic nicotine exposure. PLoS ONE 6, e28790 (2011).
36. McDonald, J.M. et al. The SHREW1 gene, frequently deleted in oligodendrogliomas, functions to inhibit cell adhesion and migration. Cancer Biol. Ther. 5, 300-304 (2006).
37. Habbig, S. et al. NPHP4, a cilia-associated protein, negatively regulates the Hippo pathway. J. Cell Biol. 193, 633-642 (2011).
38. Dixon, A.L. et al. A genome-wide association study of global gene expression. Nat. Genet. 39, 1202-1207 (2007).
39. Stranger, B.E. et al. Population genomics of human gene expression. Nat. Genet. 39, 1217-1224 (2007).
40. Veyrieras, J.B. et al. High-resolution mapping of expression-QTLs yields insight into human gene regulation. PLoS Genet. 4, e1000214 (2008).
41. Pickrell, J.K. et al. Understanding mechanisms underlying human gene expression variation with RNA sequencing. Nature 464, 768-772 (2010).
42. Montgomery, S.B. et al. Transcriptome genetics using second generation sequencing in a Caucasian population. Nature 464, 773-777 (2010).
43. Dimas, A.S. et al. Common regulatory variation impacts gene expression in a cell type-dependent manner. Science 325, 1246-1250 (2009).
44. Schadt, E.E. et al. Mapping the genetic architecture of gene expression in human liver. PLoS Biol. 6, e107 (2008).
45. Myers, A.J. et al. A survey of genetic human cortical gene expression. Nat. Genet. 39, 1494-1499 (2007).